Company profile for Halberd Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus’. The issued patents’ extracorporeal technology is applicable to a significant number of the most debilitating and oft...
Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus’. The issued patents’ extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
P.O. Box 25 Jackson Center, PA, 16133
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/03/3179185/0/en/Halberd-Corporation-Continues-Seeking-Government-Contracts-with-Scientists-at-Mississippi-State-University.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/27/3174512/0/en/Halberd-Corporation-Successfully-Demonstrates-its-Proprietary-Breakthrough-AI-Technology-for-Behavioral-Analysis-Platform.html

GLOBENEWSWIRE
27 Oct 2025

https://www.globenewswire.com/news-release/2025/09/29/3157641/0/en/Halberd-Corporation-Acquires-NeuroSense-AI-Corp-a-Revolutionary-Behavioral-Intelligence-Platform-to-Transform-TBI-Other-Research-and-Clinical-Assessment.html

GLOBENEWSWIRE
29 Sep 2025

https://www.globenewswire.com/news-release/2025/05/28/3089384/0/en/Halberd-Athena-GTX-Inc-Athena-Telemedicine-Partnership-LLC-Clinical-Study-Updates.html

GLOBENEWSWIRE
28 May 2025

https://www.globenewswire.com/news-release/2025/03/17/3043650/0/en/Progress-Update-on-Halberd-Athena-GTX-and-Athena-Telemedicine-Partnership-LLC-Joint-Projects.html

GLOBENEWSWIRE
17 Mar 2025

https://www.globenewswire.com//en/news-release/2024/10/01/2956081/0/en/Halberd-Athena-GTX-Report-Initial-Success-of-WatchDawg-PTSD-Treatment-Pilot-Study.html

GLOBENEWSWIRE
01 Oct 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty